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The pathway of surgical innovation is complex. Inherent
ethical and practical characteristics make scientific
evaluation of new techniques or devices by a definitive
randomized controlled trial (RCT) challenging.
The IDEAL Collaboration (http://www.ideal-collaboration.
net) Framework for evaluating surgical innovation describes
a five stage process - Idea, Development, Exploration,
Assessment and Long-term study.(1) Early stage studies
should be designed to facilitate and prepare the way for a
rigorous evaluation by RCT.
IDEAL Recommendations in the early stages (Idea/
Development) emphasise prospective designs, transpar-
ency and full reporting in open registries, to provide
reliable data early in the innovation development pro-
cess. At the Exploration stage, prospective observational
studies need to address factors such as case-mix, learn-
ing and outcomes, building co-operatively and explicitly
towards a definitive evaluation study, preferably an RCT,
optimising the contribution of data from non-rando-
mised prospective evaluations (Assessment stage). The
Long-term stages should be characterised by registry-
based surveillance for both new procedures and devices.
IDEAL proposals for high quality RCTs of surgical
procedures focus on three key areas: definition of the
intervention; who delivers the intervention and prefer-
ences of surgeons and patients. IDEAL Recommenda-
tions identify modifications to study design which may
help address these difficult areas. We will describe
examples of good practice using these suggested
methods.
Everyone involved in evaluating surgical innovations is
invited to join the IDEAL Collaboration community and
help further evolve methodology and reporting standards
for robust trials in surgery.
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